14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $199.92 $199.92 Thursday, 14th Sep 2023 RXDX stock ended at $199.92. During the day the stock fluctuated 0% from a day low at $199.92 to a day high of $199.92.
90 days $199.92 $199.92
52 weeks $30.75 $199.96

Historical Prometheus Biosciences Inc prices

Date Open High Low Close Volume
Nov 25, 2022 $43.00 $45.46 $43.00 $44.73 143 676
Nov 23, 2022 $46.35 $47.09 $42.98 $43.11 340 751
Nov 22, 2022 $45.84 $46.18 $44.15 $46.12 277 433
Nov 21, 2022 $45.31 $46.18 $44.37 $45.87 182 817
Nov 18, 2022 $44.67 $45.60 $44.00 $44.99 467 032
Nov 17, 2022 $47.00 $47.22 $44.30 $44.37 250 446
Nov 16, 2022 $49.14 $49.30 $47.00 $47.96 193 462
Nov 15, 2022 $50.25 $51.41 $48.35 $49.11 307 473
Nov 14, 2022 $50.07 $51.54 $49.01 $49.60 388 519
Nov 11, 2022 $49.25 $52.56 $49.00 $50.41 327 418
Nov 10, 2022 $49.13 $51.42 $46.10 $49.14 565 254
Nov 09, 2022 $47.00 $50.45 $46.50 $49.89 654 667
Nov 08, 2022 $48.16 $49.34 $46.50 $47.05 472 610
Nov 07, 2022 $49.50 $50.21 $47.50 $47.83 325 705
Nov 04, 2022 $50.26 $50.62 $47.67 $49.23 429 763
Nov 03, 2022 $51.00 $51.37 $49.41 $49.69 451 349
Nov 02, 2022 $51.00 $54.40 $50.69 $51.10 429 933
Nov 01, 2022 $53.41 $53.41 $45.78 $51.35 917 527
Oct 31, 2022 $55.30 $56.14 $51.76 $52.52 544 340
Oct 28, 2022 $54.17 $56.23 $53.31 $56.07 359 921
Oct 27, 2022 $52.55 $53.63 $50.87 $53.54 362 312
Oct 26, 2022 $51.81 $53.84 $51.21 $51.87 325 005
Oct 25, 2022 $49.78 $53.33 $49.78 $51.64 381 243
Oct 24, 2022 $49.45 $49.45 $45.84 $49.28 325 176
Oct 21, 2022 $49.07 $50.52 $48.69 $49.57 350 439
Click to get the best stock tips daily for free!

About Prometheus Biosciences Inc

Prometheus Biosciences Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated ... RXDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT